PHAXIAM Therapeutics S.A. – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 12/31/22 FY 2022

ended 12/31/21 FY 2021

ended 12/31/20 FY 2020

ended 12/31/19 FY 2019

ended 12/31/18 FY 2018

Prospectuses and Registrations Filter

Securities registration termination

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Ownership Filter

Armistice Capital, LLC

Biotechnology Value Fund L P

Biotechnology Value Fund L P

Armistice Capital, LLC

Biotechnology Value Fund L P

News Filter

Announces Intention to Voluntary Delist American Depositary Shares From the Nasdaq Capital Market

Announces Its Cash Position at the End of 2023 and Its Financial Calendar for 2024

Provides Business and Financial Update for the Third Quarter of 2023

TP ICAP Midcap Initiates Coverage of PHAXIAM Therapeutics With a “Buy” Recommendation

Announces High Coverage Performance of Its Two Anti-Staphylococcus Aureus Phages Over Clinical Strains

Proxies

No filings in this category.

Other Filter

Notice of effectiveness

Appointment of agent for service of process and undertaking

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC